Science Explorer Interactive view Map
Research facility · Tokyo · Japan

Japan Breast Cancer Research Group

Research works
22
▼ 24% vs 2013–17
Citations
2.1k
93.5 per fractional work
Top-10% rate
24.0%
record average 16.5%
Open access
54%
world 28%

Not ranked overall: Japan Breast Cancer Research Group is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which keywords describe research at Japan Breast Cancer Research Group?

By fractional works in all years, weighted toward what it does more of than the world: Hepatocellular Carcinoma, Survival, Treatment, Clinical Practice Guidelines, Liver Cancer, Management, Chemotherapy and Prognostic Factors.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 32 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 32 words, with their numbers
  1. Hepatocellular Carcinoma6▲ 131×3 topics
  2. Survival5▲ 160×2 topics
  3. Clinical Practice Guidelines4▲ 34×3 topics
  4. Treatment4▲ 15×2 topics
  5. Liver Cancer4▲ 349×1 topic
  6. Management4▲ 23×1 topic
  7. Chemotherapy4▲ 23×7 topics
  8. Prognostic Factors3▲ 30×2 topics
  9. Epidemiology3▲ 3.0×2 topics
  10. Surgical Management2▲ 25×2 topics
  11. Biliary Tract Cancer2▲ 299×1 topic
  12. Cholangiocarcinoma2▲ 133×1 topic
  13. Radiotherapy2▲ 25×3 topics
  14. Clinical Trials2▲ 12×2 topics
  15. Immunotherapy2▲ 12×4 topics
  16. Targeted Therapy2▲ 35×2 topics
  17. Antiviral Therapy2▲ 45×2 topics
  18. Immune Response2▲ 11×2 topics
  19. Liver Disease2▲ 50×3 topics
  20. Tumor Microenvironment2▲ 19×2 topics
  21. Adjuvant Therapy1▲ 57×2 topics
  22. Metastasis1▲ 18×3 topics
  23. CT Screening1▲ 104×1 topic
  24. Global Burden1▲ 11×2 topics
  25. Lung Cancer1▲ 35×1 topic
  26. Chronic Hepatitis B1▲ 101×1 topic
  27. HIF-11▲ 74×1 topic
  28. Hepatitis B Virus1▲ 101×1 topic
  29. Warburg Effect1▲ 74×1 topic
  30. NAFLD1▲ 45×1 topic
  31. NASH1▲ 45×1 topic
  32. Prognosis1▲ 16×2 topics

Which research topics does Japan Breast Cancer Research Group publish most on?

By volume in 2022–2025: Hepatocellular Carcinoma Treatment and Prognosis, BRCA gene mutations in cancer, PARP inhibition in cancer therapy and Advanced Breast Cancer Therapies.

  1. 1 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 0 works
  2. 2 BRCA gene mutations in cancer Genetics 0 works
  3. 3 PARP inhibition in cancer therapy Oncology 0 works
  4. 4 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
  5. 5 Pancreatic and Hepatic Oncology Research Oncology 0 works
  6. 6 Medical Case Reports and Studies Surgery 0 works
  7. 7 Cancer and biochemical research Molecular Biology 0 works
  8. 8 Cancer, Hypoxia, and Metabolism Cancer Research 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available54.3%not open45.7%

World: 28% of research is openly available.

with international co-authors6.8%domestic only93.2%

World: 19% is written across borders.

How has Japan Breast Cancer Research Group's research output changed?

Output in 2018–2022 was 24% lower than in 2013–2017.

199520002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Tokyo

All research institutions in Tokyo

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.